Xiuxia Zhou

Suzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

HMGB1/MYH9 suppresses PPARγ to induce lung injury in renal ischemia-reperfusion: protective effects of Rosiglitazone.

HMGB1/MYH9 suppresses PPARγ to induce lung injury in renal ischemia-reperfusion: protective effects of Rosiglitazone.

Journal: Pediatric research
Published: December 20, 2025

CXCL12 and CXCL13 as potential biomarkers for disease severity and recurrence in respiratory syncytial virus bronchiolitis.

CXCL12 and CXCL13 as potential biomarkers for disease severity and recurrence in respiratory syncytial virus bronchiolitis.

Journal: Scientific reports
Published: April 10, 2025

BRD4 PROTAC degrader MZ1 exhibits anti-B-cell acute lymphoblastic leukemia effects via targeting CCND3.

BRD4 PROTAC degrader MZ1 exhibits anti-B-cell acute lymphoblastic leukemia effects via targeting CCND3.

Journal: Hematology (Amsterdam, Netherlands)
Published: August 18, 2023

Multi-signaling pathway activation by pH responsive manganese particles for enhanced vaccination.

Multi-signaling pathway activation by pH responsive manganese particles for enhanced vaccination.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 18, 2022

Smart Nanomedicine to Enable Crossing Blood-Brain Barrier Delivery of Checkpoint Blockade Antibody for Immunotherapy of Glioma.

Smart Nanomedicine to Enable Crossing Blood-Brain Barrier Delivery of Checkpoint Blockade Antibody for Immunotherapy of Glioma.

Journal: ACS nano
Published: January 03, 2022

Rottlerin inhibits cell growth and invasion via down-regulation of EZH2 in prostate cancer.

Rottlerin inhibits cell growth and invasion via down-regulation of EZH2 in prostate cancer.

Journal: Cell cycle (Georgetown, Tex.)
Published: November 06, 2018

MiR-26b reverses temozolomide resistance via targeting Wee1 in glioma cells.

MiR-26b reverses temozolomide resistance via targeting Wee1 in glioma cells.

Journal: Cell cycle (Georgetown, Tex.)
Published: September 13, 2017

Regulation of RIP3 by the transcription factor Sp1 and the epigenetic regulator UHRF1 modulates cancer cell necroptosis.

Regulation of RIP3 by the transcription factor Sp1 and the epigenetic regulator UHRF1 modulates cancer cell necroptosis.

Journal: Cell death & disease
Published: March 28, 2017

Inhibition of Notch-1 pathway is involved in rottlerin-induced tumor suppressive function in nasopharyngeal carcinoma cells.

Inhibition of Notch-1 pathway is involved in rottlerin-induced tumor suppressive function in nasopharyngeal carcinoma cells.

Journal: Oncotarget
Published: March 28, 2017

The effects of curcumin on proliferation, apoptosis, invasion, and NEDD4 expression in pancreatic cancer.

The effects of curcumin on proliferation, apoptosis, invasion, and NEDD4 expression in pancreatic cancer.

Journal: Biochemical pharmacology
Published: March 17, 2017

Rottlerin exhibits antitumor activity via down-regulation of TAZ in non-small cell lung cancer.

Rottlerin exhibits antitumor activity via down-regulation of TAZ in non-small cell lung cancer.

Journal: Oncotarget
Published: November 02, 2016

Antitumor activity of curcumin is involved in down-regulation of YAP/TAZ expression in pancreatic cancer cells.

Antitumor activity of curcumin is involved in down-regulation of YAP/TAZ expression in pancreatic cancer cells.

Journal: Oncotarget
Published: September 02, 2016
Showing 1-12 of 19

Last Updated: 09/26/2026